by European Public Health Alliance | May 19, 2017 | Opinion
What a busy week, last week has been for pharmaceutical policy-making in Europe! The Mediterranean initiative launched last July in Athens proves to be still alive with the signing of the Valletta Declaration last week in Malta by the Health Ministers of Portugal,...
by EPHA | May 4, 2017 | Consultation Responses
Click on the button below to read EPHA’s response to the OECD online consultation on sustainable access to innovative therapies. Please note that the consultation response included EPHA’s Briefing Will fast-tracking new medicines improve affordability? DOWNLOAD...
by European Public Health Alliance | Apr 5, 2017 | Opinion
This article appeared first on The European Files, March 2017. 2016 is the year that political correctness went out the window when it comes to the debate on pharmaceuticals in Europe. The past year certainly marked a turning point and made clear that the problem of...
by EPHA | Mar 27, 2017 | News Release, Statements
Brussels, 27 March 2017 The European Public Health Alliance (EPHA) is among 30 civil society organisations from 17 European countries filing coordinated patent oppositions on Hepatitis C medicine Sofosbuvir with the European Patent Office (EPO). The development of...
by European Public Health Alliance | Mar 2, 2017 | News Release, Statements
Brussels, 2 March 2017. The European Public Health Alliance welcomes the report on access to medicines adopted by the European Parliament Plenary this morning. The Parliament’s own initiative report addresses the challenge posed to national healthcare budgets by high...
